|
08 Aug 2019 |
Bayer acquires BlueRock Therapeutics to build leading position in cell therapy
|
|
06 Aug 2019 |
Aquinox Pharmaceuticals and Neoleukin Therapeutics announce merger agreement
|
|
05 Aug 2019 |
Neuropore Therapies and BenevolentAI Enter Strategic Collaboration to Discover Novel Therapeutics Through the Application of Artificial Intelligence
|
|
05 Aug 2019 |
Sosei Heptares and Takeda Enter Into New Strategic Multi-target Research, Development and Commercialization Partnership
|
|
01 Aug 2019 |
ImCheck Therapeutics Awarded €2 Million From Bpifrance to Advance its First-in-class Immunotherapy Program Into the Clinic
|
|
01 Aug 2019 |
Rewind Therapeutics Awarded €2.9 Million VLAIO Grant to Discover and Develop Novel Drug Candidates for Myelin-related Neurological Diseases
|
|
01 Aug 2019 |
Exelixis and Aurigene Enter Into Exclusive Collaboration, Option and License Agreement to Discover and Develop Novel Therapies for Cancer
|
|
31 Jul 2019 |
REGENXBIO Announces New License Agreement with Pfizer for the Treatment of Friedreich's Ataxia Using NAV® AAV9 Vector
|
|
31 Jul 2019 |
Alizé Pharma 3 raises €67 million ($75 million) in Series A from a strong international syndicate
|
|
29 Jul 2019 |
Mylan and Upjohn, a Division of Pfizer, to Combine, Creating a New Champion for Global Health Uniquely Positioned to Fulfill the World’s Need for Medicine
|
|
27 Jul 2019 |
Zambon completes transformational acquisition of Breath Therapeutics
|
|
25 Jul 2019 |
REGENXBIO and Neurimmune Announce Collaboration to Develop Vectorized Antibodies for the Treatment of Neurodegenerative Diseases
|
|
24 Jul 2019 |
Ligand Acquires Ab Initio Biotherapeutics, an Antigen-Discovery Company
|
|
23 Jul 2019 |
IVERIC bio Announces Successful Advancement of LCA10 Minigene Program and Expansion of Orphan Gene Therapy Portfolio with USH2A-Related Inherited Retinal Diseases Program
|
|
23 Jul 2019 |
Shionogi announces out-licensing agreement with AMR Centre on COT-143, a humanized monoclonal antibody targeting the PcrV protein of Pseudomonas aeruginosa
|
|
23 Jul 2019 |
DURECT and Gilead Enter into License Agreement for Long-Acting Injectable HIV Investigational Product
|
|
21 Jul 2019 |
Gilead Sciences Licenses Respiratory and Herpes Antiviral Research Programs From Novartis
|
|
18 Jul 2019 |
Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi Therapeutics For Complement-Mediated Diseases
|
|
18 Jul 2019 |
Inflection Biosciences and AUM Biosciences Announce Global License Agreement for PIM/PI3K/mTOR Inhibitors
|
|
18 Jul 2019 |
Boehringer Ingelheim Expands Idiopathic Pulmonary Fibrosis (IPF) Pipeline Through Collaboration and License Agreement with Bridge Biotherapeutics
|
|
17 Jul 2019 |
PureTech Acquires New Clinical-Stage Program LYT-100 to Treat Lymphedema
|
|
17 Jul 2019 |
Astellas and Frequency Therapeutics Enter into License Agreement for FX-322, a Regenerative Treatment Candidate for Hearing Loss
|
|
17 Jul 2019 |
Gotham Therapeutics and Mercachem Announce Progress in Compound Library Development Tailored for Epitranscriptomic Drug Discovery
|
|
16 Jul 2019 |
Skyhawk Therapeutics Announces Agreement with Genentech to Discover and Develop Small Molecule RNA Splicing Modifiers for Oncology and Neurodegenerative Diseases
|
|
16 Jul 2019 |
Convelo Therapeutics Enters Into Collaboration and Option to Acquire Agreement With Genentech to Discover Novel Remyelinating Therapies
|
